Rhinovirus-induced VP1-specific Antibodies are Group-specific and Associated With Severity of Respiratory Symptoms

EBioMedicine

Volumn 2, Issue 1, 2015, Pages 64-70

  Niespodziana, Katarzyna ^a   Cabauatan, Clarissa R ^a   Jackson, David J ^b,c   Gallerano, Daniela ^a   Trujillo Torralbo, Belen ^b,c   del Rosario, Ajerico ^b,c   Mallia, Patrick ^b,c   Valenta, Rudolf ^a   Johnston, Sebastian L ^b,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antibody response; Asthma; Recombinant rhinovirus coat protein; Rhinovirus; Serological test

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; PROTEIN VP1; CAPSID PROTEIN; RECOMBINANT PROTEIN; VIRAL PROTEIN 1, RHINOVIRUS; VIRUS ANTIBODY; VIRUS PROTEIN;

ADULT; AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DISEASE COURSE; DISEASE SEVERITY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN RHINOVIRUS A16; HUMAN RHINOVIRUS A89; HUMAN RHINOVIRUS B14; IMMUNOBLOTTING; MALE; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RESPIRATORY TRACT DISEASE; RHINOVIRUS; RHINOVIRUS INFECTION; SYMPTOM ASSESSMENT; VIRUS GENOME; VIRUS STRAIN; ANTIBODY PRODUCTION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; VIROLOGY; YOUNG ADULT;

ADULT; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ASTHMA; CAPSID PROTEINS; CROSS REACTIONS; FEMALE; GENOME, VIRAL; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RHINOVIRUS; VIRAL PROTEINS; YOUNG ADULT;

EID: 84927725998     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2014.11.012     Document Type: Article

References (30)

1. Arden K.E., Faux C.E., O'Neill N.T., McErlean P., Nitsche A., Lambert S.B., Nissen M.D., Sloots T.P., Mackay I.M. Molecular characterization and distinguishing features of a novel human rhinovirus (HRV) C, HRVC-QCE, detected in children with fever, cough and wheeze during 2003. J. Clin. Virol. 2010, 47:219-223.
2. Bardin P.G., Fraenkel D.J., Sanderson G., van Schalkwyk E.M., Holgate S.T., Johnston S.L. Peak expiratory flow changes during experimental rhinovirus infection. Eur. Respir. J. 2000, 16:980-985.
3. Beale J., Jayaraman A., Jackson D.J., Macintyre J.D., Edwards M.R., Walton R.P., Zhu J., Ching Y.M., Shamji B., Edwards M., et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci. Transl. Med. 2014, 6:256ra134.
4. Bochkov Y.A., Gern J.E. Clinical and molecular features of human rhinovirus C. Microbes Infect. 2012, 14:485-494.
5. Bousquet J., Anto J., Sunyer J., Nieuwenhuijsen M., Vrijheid M., Keil T. Pooling birth cohorts in allergy and asthma: European Union-funded initiatives - a MeDALL, CHICOS, ENRIECO, and GA(2)LEN joint paper. Int. Arch. Allergy Immunol. 2013, 161:1-10.
6. Calhoun W.J., Dick E.C., Schwartz L.B., Busse W.W. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J. Clin. Invest. 1994, 94:2200-2208.
7. Contoli M., Message S.D., Laza-Stanca V., Edwards M.R., Wark P.A., Bartlett N.W., Kebadze T., Mallia P., Stanciu L.A., Parker H.L., et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat. Med. 2006, 12:1023-1026.
8. Corne J.M., Marshall C., Smith S., Schreiber J., Sanderson G., Holgate S.T., Johnston S.L. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002, 359:831-834.
9. Donaldson G.C., Seemungal T.A., Patel I.S., Lloyd-Owen S.J., Wilkinson T.M., Wedzicha J.A. Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur. Respir. J. 2003, 22:931-936.
10. Dostaler S.M., Olajos-Clow J.G., Sands T.W., Licskai C.J., Minard J.P., Lougheed M.D. Comparison of asthma control criteria: importance of spirometry. J. Asthma 2011, 48:1069-1075.
11. Edlmayr J., Niespodziana K., Popow-Kraupp T., Krzyzanek V., Focke-Tejkl M., Blaas D., Grote M., Valenta R. Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation. Eur. Respir. J. 2011, 37:44-52.
12. GINA.G.I.o.A. Global strategy for asthma management and prevention. Workshop Report 2004.
13. Greve J.M., Davis G., Meyer A.M., Forte C.P., Yost S.C., Marlor C.W., Kamarck M.E., McClelland A. The major human rhinovirus receptor is ICAM-1. Cell 1989, 56:839-847.
14. Grunberg K., Smits H.H., Timmers M.C., de Klerk E.P., Dolhain R.J., Dick E.C., Hiemstra P.S., Sterk P.J. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am. J. Respir. Crit. Care Med. 1997, 156:609-616.
15. Hofer F., Gruenberger M., Kowalski H., Machat H., Huettinger M., Kuechler E., Blaas D. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:1839-1842.
16. Iwasaki J., Smith W.A., Stone S.R., Thomas W.R., Hales B.J. Species-specific and cross-reactive IgG1 antibody binding to viral capsid protein 1 (VP1) antigens of human rhinovirus species A, B and C. PLoS One 2013, 8:e70552.
17. Iwasaki J., Smith W.A., Khoo S.K., Bizzintino J., Zhang G., Cox D.W., Laing I.A., Le Souef P.N., Thomas W.R., Hales B.J. Comparison of rhinovirus antibody titers in children with asthma exacerbations and species-specific rhinovirus infection. J. Allergy Clin. Immunol. 2014, 134:25-32.
18. Jackson D.J., Gangnon R.E., Evans M.D., Roberg K.A., Anderson E.L., Pappas T.E., Printz M.C., Lee W.M., Shult P.A., Reisdorf E., et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am. J. Respir. Crit. Care Med. 2008, 178:667-672.
19. Jackson D.J., Makrinioti H., Rana B.M., Shamji B.W., Trujillo-Torralbo M.B., Footitt J., Del-Rosario J., Telcian A.G., Nikonova A., Zhu J., et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am. J. Respir. Crit. Care Med. 2014, 10.1164/rccm.201406-10390C.
20. Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Lampe F., Josephs L., Symington P., O'Toole S., Myint S.H., Tyrrell D.A., et al. Community study of role of viral infections in exacerbations of asthma in 9-11year old children. BMJ 1995, 310:1225-1229.
21. Kim W.K., Gern J.E. Updates in the relationship between human rhinovirus and asthma. Allergy Asthma Immunol. Res. 2012, 4:116-121.
22. Lemanske R.F., Dick E.C., Swenson C.A., Vrtis R.F., Busse W.W. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J. Clin. Invest. 1989, 83:1-10.
23. Message S.D., Laza-Stanca V., Mallia P., Parker H.L., Zhu J., Kebadze T., Contoli M., Sanderson G., Kon O.M., Papi A., et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:13562-13567.
24. Nicholson K.G., Kent J., Ireland D.C. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993, 307:982-986.
25. Niespodziana K., Napora K., Cabauatan C., Focke-Tejkl M., Keller W., Niederberger V., Tsolia M., Christodoulou I., Papadopoulos N.G., Valenta R. Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections. FASEB J. 2012, 26:1001-1008.
26. Soto-Quiros M., Avila L., Platts-Mills T.A., Hunt J.F., Erdman D.D., Carper H., Murphy D.D., Odio S., James H.R., Patrie J.T., et al. High titers of IgE antibody to dust mite allergen and risk for wheezing among asthmatic children infected with rhinovirus. J. Allergy Clin. Immunol. 2012, 129:1499-1505. (e1495).
27. Stern D.A., Riedler J., Nowak D., Braun-Fahrlander C., Swoboda I., Balic N., Chen K.W., Vrtala S., Gronlund H., van Hage M., et al. Exposure to a farming environment has allergen-specific protective effects on TH2-dependent isotype switching in response to common inhalants. J. Allergy Clin. Immunol. 2007, 119:351-358.
28. Wark P.A., Johnston S.L., Bucchieri F., Powell R., Puddicombe S., Laza-Stanca V., Holgate S.T., Davies D.E. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 2005, 201:937-947.
29. Wos M., Sanak M., Soja J., Olechnowicz H., Busse W.W., Szczeklik A. The presence of rhinovirus in lower airways of patients with bronchial asthma. Am. J. Respir. Crit. Care Med. 2008, 177:1082-1089.
30. Zhu J., Message S.D., Qiu Y., Mallia P., Kebadze T., Contoli M., Ward C.K., Barnathan E.S., Mascelli M.A., Kon O.M., et al. Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma. Chest 2014, 145:1219-1229.